Evidence map›Paper›PMID 22228970›Full record

ArticleWorld journal of gastroenterology2012

Outcome after gastrectomy in gastric cancer patients with type 2 diabetes.

Jong Won Kim, Jae-Ho Cheong, Woo Jin Hyung, Seung-Ho Choi, Sung Hoon Noh

2 registry-linked trialsOpen access · hybridAbstract read
In one paragraph

Article in World journal of gastroenterology, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 46 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
46citing papers in PubMed, 4 pooled it
7.6field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT01373346 nacompletednot on this map

Long Limb Roux-en Y Reconstruction After Gastrectomy As A Potential Cure for Type 2 Diabetes Mellitus in Non-Obese Gastric Cancer Patients - a Pilot Project to Validate a Prospective Randomized Control Trial

TypeinterventionalSponsorGangnam Severance HospitalRan2010 to 2012Enrolled15ConditionsDiabetes Mellitus Type 2 in Nonobese, Gastric CancerArmsLong limb Roux-en Y reconstruction
NCT01518023 completednot on this map

Long Term Diabetes Improvement After Cancer Gastrectomy and Colectomy

TypeobservationalSponsorUniversity of Sao PauloRan2011 to 2011Enrolled240ConditionsDiabetes Mellitus, Prediabetes, Morbid Obesity, Gastric CancerArmsInterview, questionnaire, updated biochemical tests
3 · Its place in the literature

Who cites it

46 citing papers in PubMed, 4 syntheses or guidelines pooled it, 67 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Trial
  6. Trial
  7. Trial
  8. Trial
  9. Type 2 diabetes in patients undergoing gastric cancer surgery: areas requiring disease-specific glycemic management.Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association · 2025
    Review
  10. Review
  11. Review
  12. Article
  13. Article
  14. Article
  15. Remission of type 2 diabetes after gastrectomy for gastric cancer: diabetes prediction score.Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association · 2022
    Article
  16. Article
  17. Review
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Jong Won KimDepartment of Surgery, Gangnam Severance Hospital, Yonsei University College of Medicine, Seoul 135-720, South Korea.
Jae-Ho Cheong
Woo Jin Hyung
Seung-Ho Choi
Sung Hoon Noh
Gangnam Severance Hospital · KR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

aimTo evaluate the prognosis of type II diabetes mellitus (T2DM) after gastrectomy and related factors in gastric cancer patients.

methods403 gastric cancer patients with T2DM were studied, who underwent gastrectomy between May 2003 and September 2009. A review of medical records and telephone interviews was performed in this cross-sectional study. The factors included in the statistical analysis were as follows: gender, age, type of surgery, preoperative body mass index (BMI), current BMI, BMI reduction ratio, preoperative insulin or oral diabetic medicine requirement, follow-up duration, and current state of diabetes. Assessment of diabetes status after surgery was classified into four categories according to the change in hypoglycemic agents after surgery and present status of T2DM: resolution, improvement, same, and worse.

resultsThe mean follow-up duration was 33.7 mo (± 20.6 mo), preoperative BMI was 24.7 kg/m(2) (± 3.0 kg/m(2)), and BMI reduction ratio was 9.8% (± 8.6%). After surgery, T2DM was cured in 58 patients (15.1%) and was improved in 117 patients (30.4%). According to the type of surgery, the BMI reduction ratio was significantly higher in the total gastrectomy and Roux-en-Y reconstruction group [14.2% ± 9.2% vs 9.2% ± 7.7% (Billroth II group), P < 0.001] and significantly lower in the subtotal gastrectomy and Billroth I reconstruction group [7.6% ± 8.0%, 9.2% ± 7.7% (Billroth II group), P < 0.001]. The BMI reduction ratio, follow-up duration after surgery, type of surgery, extent of gastrectomy, and performance of duodenal bypass were significantly correlated to the course of T2DM (P < 0.05). The BMI reduction ratio was the most influential factor on T2DM status. In a subgroup analysis of patients with a BMI reduction ratio of 10% or less (n = 206), T2DM was cured in 15 (7.6%) patients and was improved in 57 (28.8%) patients after surgery, and only the duration of surgery was significantly correlated to T2DM status (P = 0.022).

conclusionThe course of T2DM was significantly correlated to the BMI reduction ratio but not to the type of surgery without a significant change in BMI.

Indexed as

AgedBody Mass IndexCross-Sectional StudiesDiabetes Mellitus, Type 2FemaleFollow-Up StudiesGastrectomyHumansMaleMiddle AgedObesity, MorbidPrognosisRetrospective StudiesStomach NeoplasmsTreatment OutcomeWeight LossBariatric surgeryDiabetes mellitusGastric cancerMetabolic surgery

Identifiers

PMID22228970
PMCPMC3251805
OpenAlexW1981180231

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.